These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 16785738

  • 21. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 22. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?
    Deegens JK, Assmann KJ, Steenbergen EJ, Hilbrands LB, Gerlag PG, Jansen JL, Wetzels JF.
    Neth J Med; 2005 Nov; 63(10):393-8. PubMed ID: 16301760
    [Abstract] [Full Text] [Related]

  • 23. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Hamed RM.
    J Nephrol; 1997 Nov; 10(5):266-70. PubMed ID: 9364319
    [Abstract] [Full Text] [Related]

  • 24. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD, MacLeod R, Rigby E, Clark AG.
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [Abstract] [Full Text] [Related]

  • 25. Effects of cyclosporine, azathioprine and prednisone on Kimura's disease and focal segmental glomerulosclerosis in renal transplant patients.
    Senel MF, Van Buren CT, Etheridge WB, Barcenas C, Jammal C, Kahan BD.
    Clin Nephrol; 1996 Jan; 45(1):18-21. PubMed ID: 8616952
    [Abstract] [Full Text] [Related]

  • 26. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ.
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [Abstract] [Full Text] [Related]

  • 27. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 28. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 May; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F, Ahmad TM, Anwar S.
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [Abstract] [Full Text] [Related]

  • 30. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
    Pokhariyal S, Gulati S, Prasad N, Sharma RK, Singh U, Gupta RK, Mittal S, Mehta B.
    J Nephrol; 2003 Jun; 16(5):691-6. PubMed ID: 14733415
    [Abstract] [Full Text] [Related]

  • 31. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF, Branten AJ, Deegens JK, Steenbergen E, Wetzels JF.
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [Abstract] [Full Text] [Related]

  • 32. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Berden JH, Dutch Working Party on systemic lupus erythematosus.
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [Abstract] [Full Text] [Related]

  • 33. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
    Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G.
    Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
    [Abstract] [Full Text] [Related]

  • 34. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P, Jesdapatarakul S.
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [Abstract] [Full Text] [Related]

  • 35. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [Abstract] [Full Text] [Related]

  • 36. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children].
    Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E.
    Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
    Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F.
    Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
    [Abstract] [Full Text] [Related]

  • 38. Raised serum creatinine at presentation does not adversely affect steroid response in primary focal segmental glomerulosclerosis in adults.
    Jafry N, Ahmed E, Mubarak M, Kazi J, Akhter F.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1101-6. PubMed ID: 21804085
    [Abstract] [Full Text] [Related]

  • 39. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C.
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):479-89. PubMed ID: 8227973
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis.
    Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J.
    Nefrologia; 2011 Aug; 31(3):286-91. PubMed ID: 21468162
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.